Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 167   

Articles published

AZN 4,952.74 -24.76 (-0.50%)
price chart
AstraZeneca, Rivals Take Aim at Lung Cancer Combo Therapies
For AstraZeneca Plc, when it comes to beating cancer there's strength in numbers. The drugmaker is combining two medicines to overcome lung cancer's defenses against an immune system attack, an approach that became more attractive after rivals' studies ...
Wil AstraZeneca plc (ADR) (AZN) Compete in Lung Cancer Treatment?  The Voice Observer
AstraZeneca plc 20.6% Potential Decrease Indicated by Credit Suisse
AstraZeneca plc with EPIC/TICKER LON:AZN had its stock rating noted as 'Reiterates' with the recommendation being set at 'UNDERPERFORM' this morning by analysts at Credit Suisse.
AstraZeneca plc (AZN) Rating Reiterated by JPMorgan Chase & Co.  Community Financial News
Stock to Watch: AstraZeneca plc (NYSE:AZN)
AstraZeneca plc (ADR (NYSE:AZN) share price plunged -2.93% or -0.94 points to reach at $31.12 during previous trading session.
Recent analysts Ratings: AstraZeneca PLC (NYSE:AZN)  News Oracle
AstraZeneca plc (AZN) Earns Buy Rating from Deutsche Bank AG  The Cerbat Gem
Future Average Earnings Expectations For: Astrazeneca PLC (NYSE:AZN) , Ionis ...
On 10/19/2016, Astrazeneca PLC (NYSE:AZN) finished the previous buying and selling session with the price of $30.78. The stock revealed the change of -1.57% with down momentum.
AstraZeneca licenses respiratory drug to Insmed
The deal adds AstraZeneca's AZD7986 compound to Insmed's pipeline. AZD7986 is designed to stop an enzyme that regulates inflammation in the respiratory system.
AstraZeneca plc (ADR) (NYSE:AZN) Gets UK Approval For Tagrisso
In other news, AstraZeneca has recently entered into a licensing agreement with Aralez Pharmaceuticals Trading for the commercialization of branded and generic Toprol-XL (metoprolol succinate) in the United States, a control treatment for angina, heart ...
AstraZeneca sells US rights for Toprol-XL  MarketWatch
Aralez To Acquire US Rights To AstraZeneca's Beta Blocker Toprol-XL For ...  Nasdaq
AstraZeneca: FDA to review hyperkalaemia drug
LONDON--Pharmaceutical company AstraZeneca PLC (AZN.LN) said Tuesday the U.S. Food and Drug Administration accepted a complete re-submission of a new drug application for a potential new medicine for treating high potassium levels in the human ...
AstraZeneca: FDA To Review Re-submission Of NDA For ZS-9 - Quick Facts  Nasdaq
AstraZeneca PLC Consolidating 350 California Jobs to the Bay Area
AstraZeneca (AZN), with worldwide headquarters in Cambridge, UK, announced this week that it is consolidating some of its California staffers at The Cove at Oyster Point in South San Francisco.
AstraZeneca plc (AZN) PT Raised to GBX 6000 at Jefferies Group
AstraZeneca plc logo AstraZeneca plc (LON:AZN) had its price objective hoisted by research analysts at Jefferies Group from GBX 5,800 ($71.78) to GBX 6,000 ($74.26) in a research note issued to investors on Thursday.
Bryan Garnier issued a report on AstraZeneca PLC (LON:AZN), retaining its ...  Breaking Finance News
AstraZeneca signs $330 mln deal with J&J affiliate
LONDON--AstraZeneca PLC (AZN.LN) said Friday has sold its rights outside the U.S. for nasal spray Rhinocourt Aqua to Johnson & Johnson JNJ, +0.24% affiliate Cilag GmbH International for $330 million.